WEST PHARMACEUTICAL SERVICES INC
For the period ended May 4, 2026. Filed Mar 12, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 4, 2026 · Filed Mar 12, 2026
Contents
External Benchmarking
In support of our compensation philosophy, we reference a range of compensation values of two compensation comparator groups, which we refer to as the “Business Segment Group” and the “Broad Talent Market Group.” Data from both the Business Segment Group (which generally is applicable to the CEO and CFO) and Broad Talent Market Group (applicable to all executive officers) are used holistically to determine competitive pay practices for our CEO and executive officers. While median data are the primary reference used in setting compensation opportunities, the full range of compensation values are considered based on individual role and incumbent circumstances.
The Business Segment Group is composed of public companies with operational and customer characteristics similar to our own business operations. These companies are initially identified by Pay Governance and subsequently approved by the Committee with input from Management based on the following criteria: (1) size (approximately one-half to two times our annual sales); (2) industry (healthcare equipment/supplies, industrial manufacturing and life sciences tools/services); and (3) operating structure such as:
| ● | Global footprint with multi-plant manufacturing capabilities |
| ● | Similar raw materials and products (elastomers, plastics, metals), and similar intellectual property profile |
| ● | Similar customer characteristics (complex sales cycle, quality requirements, regulatory requirements) |
The Broad Talent Market Group is a larger and broader sampling of size-appropriate companies that participate in the WTW (formerly Willis Towers Watson) annual executive compensation database. Unlike the Business Segment Group, the Committee does not select individual members of the Broad Talent Market Group. Companies within the Broad Talent Market Group operate in industries that are similar, but not identical to our own industry. Industries included are Pharmaceuticals and Life Sciences; Healthcare; Natural Resources; and Technology and Media.
Given our size and business portfolio, it is challenging to identify a robust sample of appropriate market compensation peers that fit conventional criteria. Therefore, we believe that using a balance of business and talent market references that reflect companies with which we compete for business and capital, and more broadly, those with which we compete for talent, provides the Committee with decision-quality data and context, and reasonably represents our labor market for executive talent.
The Committee believes it is good governance to annually review our two compensation comparator group approach to ensure the comparator sets remain appropriate and to adjust based on: (1) our enterprise strategy; (2) the markets in which we compete for business, including emerging or more technical markets; (3) the areas in which we compete for talent, business
Compensation Tables I 45
and capital; and (4) our size and organizational complexity. The last significant update to our comparator groups occurred in 2022.
The chart below lists each company included in the 2025 Business Segment Group.
| 2025 Business Segment Group | ||
|---|---|---|
| ●Agilent Technologies, Inc.●AptarGroup, Inc.●Bio-Rad Laboratories, Inc.●DENTSPLY SIRONA Inc.●Edwards Lifesciences Corporation | ●Haemonetics Corporation●Hologic, Inc.●IDEXX Laboratories, Inc.●Integer Holdings Corporation●Integra LifeSciences | ●ResMed Inc.●Revvity, Inc.●STERIS plc●Teleflex Incorporated●The Cooper Companies, Inc. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.